Class 2 medicines recall: Bricanyl Injection 0.5 mg/ml solution for injection or infusion

AstraZeneca UK Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that it is recalling one batch of Bricanyl Injection 0.5 mg/ml solution for injection or infusion as a precautionary measure due to out of specification results for a routinely tested known impurity during stability testing.

Further information including the affected batch number, a brief description of the problem and advice for healthcare professionals can be found on the MHRA website.